Search results

Ken Phares demystifies ICH Q14 & Q2(R2) guidelines with practical strategies for analytical procedure development, risk-based method design, and lifecycle management.

Discover seven tips from expert toxicologist and consultant Robin Guy on tackling key challenges for in vitro NAMs studies, from data integrity to regulatory acceptance.

Toxicologist Mary Ellen Cosenza explains the FDA’s 2025 roadmap for phasing out animal testing and its implications for drug development and safety.

Bill Brock reflects on his career in toxicology spanning over 40 years, sharing insights on mentorship, new technologies, and the future of toxicology and preclinical research.

Discover Maatangi Sachchithanandam’s career journey, and how saying yes to unexpected opportunities built a rewarding career in drug development at Altasciences.